Viewing Study NCT02629692


Ignite Creation Date: 2025-12-24 @ 3:57 PM
Ignite Modification Date: 2026-01-16 @ 10:43 AM
Study NCT ID: NCT02629692
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-31
First Post: 2015-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies
Sponsor: Sun Pharma Advanced Research Company Limited
Organization: